Retractable Technologies claims $5 million win in patent suit against Becton Dickinson

Retractable Tech claims $5M win in Becton suit

LITTLE ELM, Texas — Retractable Technologies Inc. said Monday that it has won a $5 million patent infringement case against Becton, Dickinson and Co.

Retractable Technologies, which makes safety syringes and blood collection devices, charged Becton Dickinson of violating intellectual property rights on two of its syringe designs.

A judge in the U.S. District Court for the Eastern District of Texas ordered an injunction blocking Becton Dickinson from making or selling the syringe. The injunction won’t go into place for a year or until Becton Dickinson is finished appealing the ruling.

Becton Dickinson did not immediately respond to a request for comment.

Shares of Retractable Technologies added 5 cents, or 3 percent, to $1.70 in afternoon trading. Becton Dickinson shares climbed 37 cents to $71.86.